Haptoglobin Polymorphism Predicts 30-Day Mortality and Heart Failure in Patients With Diabetes and Acute Myocardial Infarction
- 1 September 2005
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (9), 2802-2806
- https://doi.org/10.2337/diabetes.54.9.2802
Abstract
Patients with diabetes presenting with acute myocardial infarction (AMI) have an increased rate of death and heart failure. Patients with diabetes homozygous for the haptoglobin (Hp) 1 allele (Hp 1-1) develop fewer vascular complications. We tested the hypothesis that Hp type is related to the outcome of patients with diabetes presenting with AMI. We prospectively assessed the relationship between Hp type and 30-day mortality and heart failure in 1,437 patients with AMI (506 with diabetes). Multivariate logistic regression identified a significant interaction between Hp type and diabetes status on these outcome measures. Hp type was not related to outcome among patients without diabetes. In contrast, Hp 1-1 was associated with a strong protective effect with regard to the primary end point of death (OR 0.14, P = 0.015) and for death and heart failure (OR 0.35; 95% CI 0.15–0.86, P = 0.018) among patients with diabetes. Finally, among patients with diabetes, Hp 1-1 was associated with smaller infarct size. This study demonstrates that in patients with diabetes and AMI, the Hp type is an important determinant of clinical outcome and infarct size.Keywords
This publication has 24 references indexed in Scilit:
- Haptoglobin Genotype– and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In VivoCirculation Research, 2005
- Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular DiseaseCirculation Research, 2003
- Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetesJournal of the American College of Cardiology, 2002
- Structure-function analysis of the antioxidant properties of haptoglobinBlood, 2001
- Haptoglobin Phenotype and Vascular Complications in Patients with DiabetesNew England Journal of Medicine, 2000
- Haptoglobin Genotype as a Risk Factor for Diabetic RetinopathyJAMA, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- Genetics of diabetic nephropathy: Evidence for major and minor gene effectsKidney International, 1999
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.JCI Insight, 1997
- The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosisJournal of the American College of Cardiology, 1989